Creating immune privilege: active local suppression that benefits friends, but protects foes.
about
The immunity-related GTPase Irgm1 promotes the expansion of activated CD4+ T cell populations by preventing interferon-gamma-induced cell deathHalofuginone inhibits TH17 cell differentiation by activating the amino acid starvation responseClinical Development of the E75 Vaccine in Breast CancerIntrinsic and Tumor Microenvironment-Induced Metabolism Adaptations of T Cells and Impact on Their Differentiation and FunctionA Metabolic Immune Checkpoint: Adenosine in Tumor MicroenvironmentAssociation of Interferon Gamma +874T/A Polymorphism and Leukemia Risk: A Meta-AnalysisThe Role of CD4 T Cell Memory in Generating Protective Immunity to Novel and Potentially Pandemic Strains of InfluenzaRole of neuroinflammation in the emotional and cognitive alterations displayed by animal models of obesityThe Role of the Immune Response in Chlamydia trachomatis Infection of the Male Genital Tract: A Double-Edged SwordMetabolic reprogramming and metabolic dependency in T cellsWays to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytesImmunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancerTissue engineering tools for modulation of the immune responseImmune escape mechanisms as a guide for cancer immunotherapyAdvances of immunotherapy in small cell lung cancerThe Kynurenine Pathway Is a Double-Edged Sword in Immune-Privileged Sites and in Cancer: Implications for ImmunotherapyResearch progress of indoleamine 2,3-dioxygenase inhibitorsImmune heterogeneity in neuroinflammation: dendritic cells in the brainArginine deprivation and immune suppression in a mouse model of Alzheimer's diseaseInduction of IDO by bacille Calmette-Guérin is responsible for development of murine depressive-like behaviorNatural CD4+ T-cell responses against indoleamine 2,3-dioxygenaseModulators of arginine metabolism support cancer immunosurveillance.Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.A phase I trial of a human papillomavirus DNA vaccine for HPV16+ cervical intraepithelial neoplasia 2/3.Extracellular adenosine-mediated modulation of regulatory T cells.What causes alopecia areata?B-lymphoid cells with attributes of dendritic cells regulate T cells via indoleamine 2,3-dioxygenaseInduction of IDO-1 by immunostimulatory DNA limits severity of experimental colitis.M. tuberculosis induces potent activation of IDO-1, but this is not essential for the immunological control of infection.Networked T cell death following macrophage infection by Mycobacterium tuberculosis.IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation.Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancerA first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumorsDeficient tryptophan catabolism along the kynurenine pathway reveals that the epididymis is in a unique tolerogenic state.Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase.Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators.Leishmania major attenuates host immunity by stimulating local indoleamine 2,3-dioxygenase expression.Induction and role of indoleamine 2,3 dioxygenase in mouse models of influenza a virus infectionSmall intestine CD11c+ CD8+ T cells suppress CD4+ T cell-induced immune colitis.
P2860
Q24643456-5E285898-F00C-4FCE-865C-913BF50A8F44Q24648465-37410E38-CEDC-4E55-ADD9-55F2B9DCCF8DQ26745440-7D6C4A9B-75B1-4061-99EB-2238F14A76FAQ26749556-2F319E96-5494-4956-A4DA-7B0296314247Q26749571-F81884A9-3C0D-4CD8-AC48-6A7098F163E9Q26750761-19929759-7157-4D85-B56E-827E364C9893Q26772701-C8FDE176-26B1-4F72-BDD6-A99D46FEAED1Q26802171-A28C2988-1878-406F-A655-D9D61DAED23EQ26851537-7F9AA3E1-A2CB-4B45-A752-00477A867CC9Q26864319-F44EAB97-9BEE-46E6-9DDE-E46CF8767968Q26991991-6B1B876B-8945-4222-998D-B259C1DAC606Q26996829-EAEA18FF-8A7D-40E1-8DED-33DD98A59A54Q27023419-7D35EC50-B82E-46DD-B1FB-B83C979CC076Q27024502-11358D2A-75F4-41A4-8AB8-12353BC3EFF8Q27027662-A7DBE538-A542-499C-A3C2-1F7970F86EFBQ28073631-E59E2661-410D-499C-9A87-4298F5F692EFQ28257093-9F5F9DEA-6467-4E40-A0EB-0337C86D2FA1Q28385127-8DFD5DB8-5149-4F58-BB26-FCC39E3CA613Q28391826-1BEE47A0-DA90-4131-88C7-BC7254542BD7Q28508390-991F5F93-D936-407E-9F0B-C409970D17EAQ28730430-91B63CAC-01FD-4244-BD08-3F549A0C44B2Q33398779-9C241E7F-CEE1-4D38-80A3-C0271A288F90Q33587443-0218F48F-FC7F-4DD4-80EA-A070C5014484Q33788049-15001F0A-4782-401D-9D6A-886ADC604A97Q33834057-874ADBD0-9B49-467E-A10E-9F452C7EA95EQ33878542-D0FA9C9E-399E-47E2-8AB9-952FB7F437A5Q33889367-F0D432B7-FF97-47A7-B8BD-BEFE39D65C52Q33934819-3164C1A0-ED63-43CB-A218-5041E1830948Q34154099-8C1F4222-26CB-4713-A4AE-832E4FDACA30Q34287451-C2CC98D4-8E2D-4976-947A-7B18084671DAQ34295929-14C07E11-FDE9-42A0-92D6-482D69D7A353Q34396547-DADB214C-A34F-4506-BB96-AE2015149B02Q34414152-6F690814-0997-49D9-912F-102BE5FD4069Q34483473-D0E138F7-2C8C-4544-AB5F-82B82FEDE1F9Q34624242-9FDF9D3D-9B4B-490F-B7BC-871E98221B47Q34657500-7030AC64-B8D4-4FD3-9061-9453ECF3A846Q34707334-C55DD7FF-571B-42A2-8677-05DF8CB27680Q34772767-30E55712-F7C5-4CF7-8F5A-C149B8BD391DQ34778943-D671636C-F15E-4739-809E-B9B36DC16472Q35057054-1C1CDFC6-2451-41AA-BB0B-875C7321FE3D
P2860
Creating immune privilege: active local suppression that benefits friends, but protects foes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Creating immune privilege: act ...... ts friends, but protects foes.
@en
Creating immune privilege: act ...... ts friends, but protects foes.
@nl
type
label
Creating immune privilege: act ...... ts friends, but protects foes.
@en
Creating immune privilege: act ...... ts friends, but protects foes.
@nl
prefLabel
Creating immune privilege: act ...... ts friends, but protects foes.
@en
Creating immune privilege: act ...... ts friends, but protects foes.
@nl
P356
P1476
Creating immune privilege: act ...... its friends, but protects foes
@en
P2093
Andrew L Mellor
P356
10.1038/NRI2233
P577
2008-01-01T00:00:00Z